Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Hepatology (Baltimore, Md.)|June 18, 2016
Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinomaCarolin Ploeger, Nina Waldburger, Angelika Fraas, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 26, 2017
Identification of the Consistently Altered Metabolic Targets in Human Hepatocellular CarcinomaZeribe Chike Nwosu, Dominik Andre Megger, Seddik Hammad, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|September 4, 2023
The role of bariatric surgery on beta-cell function and insulin resistance in patients with nonalcoholic fatty liver disease and steatohepatitisAdisa Poljo, Stephan Kopf, Alba Sulaj, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 20, 2019
Random gene sets in predicting survival of patients with hepatocellular carcinomaTimo Itzel, Rainer Spang, Thorsten Maass, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 8, 2020
Impact of Type 2 Diabetes on Oncologic Outcomes of Hepatocellular Carcinomas in Non-Cirrhotic, Non-alcoholic Steatohepatitis: a Matched-Pair AnalysisAdrian T Billeter, Philip C Müller, Thomas Albrecht, et al.
Cell Death & Disease|December 1, 2020
Prohibitin, STAT3 and SH2D4A physically and functionally interact in tumor cell mitochondriaCarolin Ploeger, Thorben Huth, Raisatun Nisa Sugiyanto, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2024
Small-RNA sequencing reveals potential serum biomarkers for gallbladder cancer: Results from a three-stage collaborative study of large European prospective cohortsAlice Blandino, Dominique Scherer, Felix Boekstegers, et al.
Histopathology|January 29, 2017
DMBT1 expression in biliary carcinogenesis with correlation of clinicopathological dataBenjamin Goeppert, Stephanie Roessler, Natalia Becker, et al.
Oncogene|March 18, 2023
Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinomaQiangnu Zhang, Lingfeng Xiong, Teng Wei, et al.
British Journal of Cancer|October 14, 2015
Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancerBenjamin Goeppert, Lena Frauenschuh, Manuela Zucknick, et al.
Pageof 12